ZA200408273B - Method for manufacture of sertindole - Google Patents
Method for manufacture of sertindole Download PDFInfo
- Publication number
- ZA200408273B ZA200408273B ZA200408273A ZA200408273A ZA200408273B ZA 200408273 B ZA200408273 B ZA 200408273B ZA 200408273 A ZA200408273 A ZA 200408273A ZA 200408273 A ZA200408273 A ZA 200408273A ZA 200408273 B ZA200408273 B ZA 200408273B
- Authority
- ZA
- South Africa
- Prior art keywords
- chloro
- indole
- copper
- ethylenediamine
- reaction
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 39
- 238000004519 manufacturing process Methods 0.000 title claims description 25
- GZKLJWGUPQBVJQ-UHFFFAOYSA-N sertindole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C(C2CCN(CCN3C(NCC3)=O)CC2)=C1 GZKLJWGUPQBVJQ-UHFFFAOYSA-N 0.000 title claims description 13
- 229960000652 sertindole Drugs 0.000 title claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 25
- 150000001879 copper Chemical class 0.000 claims description 20
- 239000003446 ligand Substances 0.000 claims description 19
- MYTGFBZJLDLWQG-UHFFFAOYSA-N 5-chloro-1h-indole Chemical compound ClC1=CC=C2NC=CC2=C1 MYTGFBZJLDLWQG-UHFFFAOYSA-N 0.000 claims description 17
- JYEKQDWSLSXYTJ-UHFFFAOYSA-N 5-chloro-1-(4-fluorophenyl)indole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C=C1 JYEKQDWSLSXYTJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000002585 base Substances 0.000 claims description 14
- 230000003197 catalytic effect Effects 0.000 claims description 13
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 claims description 10
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 10
- 150000001450 anions Chemical class 0.000 claims description 10
- 229910021589 Copper(I) bromide Inorganic materials 0.000 claims description 8
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 8
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 8
- 239000010949 copper Substances 0.000 claims description 8
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical group [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- -1 Cul Inorganic materials 0.000 claims description 5
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical class C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims description 5
- AITNMTXHTIIIBB-UHFFFAOYSA-N 1-bromo-4-fluorobenzene Chemical group FC1=CC=C(Br)C=C1 AITNMTXHTIIIBB-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- SSJXIUAHEKJCMH-UHFFFAOYSA-N cyclohexane-1,2-diamine Chemical compound NC1CCCCC1N SSJXIUAHEKJCMH-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- KGNQDBQYEBMPFZ-UHFFFAOYSA-N 1-fluoro-4-iodobenzene Chemical compound FC1=CC=C(I)C=C1 KGNQDBQYEBMPFZ-UHFFFAOYSA-N 0.000 claims description 3
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- UDGSVBYJWHOHNN-UHFFFAOYSA-N n',n'-diethylethane-1,2-diamine Chemical compound CCN(CC)CCN UDGSVBYJWHOHNN-UHFFFAOYSA-N 0.000 claims description 3
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 2
- 150000004679 hydroxides Chemical class 0.000 claims description 2
- 235000021317 phosphate Nutrition 0.000 claims description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 6
- 238000006254 arylation reaction Methods 0.000 description 6
- 229910052802 copper Inorganic materials 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- JDOHKGNGBGUGTR-UHFFFAOYSA-N 1-(4-fluorophenyl)indole Chemical compound C1=CC(F)=CC=C1N1C2=CC=CC=C2C=C1 JDOHKGNGBGUGTR-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000561 anti-psychotic effect Effects 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 150000003346 selenoethers Chemical class 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- SSJXIUAHEKJCMH-PHDIDXHHSA-N (1r,2r)-cyclohexane-1,2-diamine Chemical compound N[C@@H]1CCCC[C@H]1N SSJXIUAHEKJCMH-PHDIDXHHSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RJCGZNCCVKIBHO-UHFFFAOYSA-N 1-chloro-4-fluorobenzene Chemical compound FC1=CC=C(Cl)C=C1 RJCGZNCCVKIBHO-UHFFFAOYSA-N 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 238000006887 Ullmann reaction Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 150000001500 aryl chlorides Chemical class 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- UZZWBUYVTBPQIV-UHFFFAOYSA-N dme dimethoxyethane Chemical compound COCCOC.COCCOC UZZWBUYVTBPQIV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 235000011182 sodium carbonates Nutrition 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200200480 | 2002-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200408273B true ZA200408273B (en) | 2006-07-26 |
Family
ID=37952025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200408273A ZA200408273B (en) | 2002-03-27 | 2004-10-13 | Method for manufacture of sertindole |
Country Status (17)
Country | Link |
---|---|
EP (2) | EP1661887A1 (ja) |
JP (1) | JP2005531519A (ja) |
KR (1) | KR20040095332A (ja) |
CN (1) | CN100528863C (ja) |
AR (1) | AR039116A1 (ja) |
AU (1) | AU2003215528B2 (ja) |
BR (1) | BR0308627A (ja) |
CA (1) | CA2480239C (ja) |
CO (1) | CO5611197A2 (ja) |
EA (1) | EA007009B1 (ja) |
ME (1) | MEP6008A (ja) |
NZ (1) | NZ535533A (ja) |
PL (1) | PL371585A1 (ja) |
RS (1) | RS85004A (ja) |
UA (1) | UA78300C2 (ja) |
WO (1) | WO2003080597A1 (ja) |
ZA (1) | ZA200408273B (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2494142A1 (en) * | 2002-08-02 | 2004-02-12 | Rhodia Pharma Solutions Inc. | Copper catalyzed arylation |
RU2436490C2 (ru) | 2006-07-07 | 2011-12-20 | Пласт 2000 С.Р.Л. | Заварочный аппарат (варианты) |
CN101591330B (zh) * | 2009-06-29 | 2013-03-06 | 上海医药工业研究院 | 舍吲哚晶型及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
US6335463B1 (en) * | 1997-05-09 | 2002-01-01 | H. Lundbeck A/S | Method of manufacturing sertindole |
WO1999018057A1 (en) * | 1997-10-06 | 1999-04-15 | Massachusetts Institute Of Technology | Preparation of diaryl ether by condensation reactions |
-
2003
- 2003-03-24 AR ARP030101015A patent/AR039116A1/es unknown
- 2003-03-26 AU AU2003215528A patent/AU2003215528B2/en not_active Ceased
- 2003-03-26 PL PL03371585A patent/PL371585A1/xx not_active Application Discontinuation
- 2003-03-26 NZ NZ535533A patent/NZ535533A/en not_active IP Right Cessation
- 2003-03-26 RS YU85004A patent/RS85004A/sr unknown
- 2003-03-26 CN CNB038070111A patent/CN100528863C/zh not_active Expired - Fee Related
- 2003-03-26 UA UA20041008714A patent/UA78300C2/uk unknown
- 2003-03-26 WO PCT/DK2003/000208 patent/WO2003080597A1/en not_active Application Discontinuation
- 2003-03-26 KR KR10-2004-7015339A patent/KR20040095332A/ko not_active Application Discontinuation
- 2003-03-26 EA EA200401261A patent/EA007009B1/ru not_active IP Right Cessation
- 2003-03-26 CA CA2480239A patent/CA2480239C/en not_active Expired - Fee Related
- 2003-03-26 ME MEP-60/08A patent/MEP6008A/xx unknown
- 2003-03-26 EP EP05023338A patent/EP1661887A1/en not_active Withdrawn
- 2003-03-26 BR BR0308627-5A patent/BR0308627A/pt not_active IP Right Cessation
- 2003-03-26 EP EP03744772A patent/EP1490353A1/en not_active Ceased
- 2003-03-26 JP JP2003578351A patent/JP2005531519A/ja active Pending
-
2004
- 2004-10-13 CO CO04102837A patent/CO5611197A2/es not_active Application Discontinuation
- 2004-10-13 ZA ZA200408273A patent/ZA200408273B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CO5611197A2 (es) | 2006-02-28 |
BR0308627A (pt) | 2005-02-15 |
KR20040095332A (ko) | 2004-11-12 |
CN1642942A (zh) | 2005-07-20 |
MEP6008A (xx) | 2010-02-10 |
WO2003080597A1 (en) | 2003-10-02 |
JP2005531519A (ja) | 2005-10-20 |
EP1661887A1 (en) | 2006-05-31 |
AR039116A1 (es) | 2005-02-09 |
EP1490353A1 (en) | 2004-12-29 |
EA007009B1 (ru) | 2006-06-30 |
AU2003215528B2 (en) | 2009-05-28 |
UA78300C2 (en) | 2007-03-15 |
NZ535533A (en) | 2007-01-26 |
CN100528863C (zh) | 2009-08-19 |
CA2480239C (en) | 2010-11-23 |
EA200401261A1 (ru) | 2005-02-24 |
AU2003215528A1 (en) | 2003-10-08 |
CA2480239A1 (en) | 2003-10-02 |
PL371585A1 (en) | 2005-06-27 |
RS85004A (en) | 2006-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1914177B (zh) | 具有轴不对称性的光学活性季铵盐以及使用该季铵盐得到的α-氨基酸及其衍生物的制备方法 | |
US20210188771A1 (en) | Process for the Preparation of Methyl 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylate | |
Hau et al. | Enantioselective Brønsted base catalyzed [4+ 2] cycloaddition using novel amino-substituted tetraphenylene derivatives | |
CN102015625A (zh) | 取代联苯胺的制备方法 | |
EP2102182B1 (en) | Catalytic process for asymmetric hydrogenation | |
ZA200408273B (en) | Method for manufacture of sertindole | |
WO2010004957A1 (ja) | キラルなイリジウムアクア錯体およびそれを用いた光学活性ヒドロキシ化合物の製造方法 | |
US20090264656A1 (en) | Method for manufacture of sertindole | |
CN110256441A (zh) | 一种巴瑞克替尼的制备方法 | |
CN102791661B (zh) | 二氟环丙烷化合物的制造方法 | |
JP2012082155A (ja) | トリアゾリウム塩及びその製造方法、アジドアルコール並びに不斉反応によるアルキル化オキシインドールの製造方法 | |
CN104163777B (zh) | 一种合成甲腈化合物的方法及其在伊伐布雷定合成中的应用 | |
US20020128478A1 (en) | Process for a carbon-carbon coupling reaction of aryl halides with olefins by heterogeneous catalysts | |
WO2009157386A1 (ja) | 光学活性アミン化合物の製造方法 | |
WO2007137042A2 (en) | Process for preparing 7- (acryl0yl) -ind0les | |
KR20150043494A (ko) | 치환된 감마 락탐의 합성을 위한 공정 | |
CN111018734B (zh) | 一种盐酸西那卡塞中间体的合成方法 | |
JP2997763B2 (ja) | 第3級アミン類の製造法 | |
WO2007074686A1 (ja) | 光学活性n-(3-ハロ-2-ヒドロキシプロピル)フタルイミドの製造法 | |
JPH11302236A (ja) | 光学活性β−アミノケトン類の製造方法、および光学活性パラジウム複核錯体とその製造方法 | |
WO2005090290A1 (ja) | シタロプラムの製造方法ならびにその中間体およびその製造方法 | |
EP4165010A1 (en) | Process of making roxadustat | |
KR101404614B1 (ko) | 키랄 알파-클로로-알파-플루오로-베타-케토 포스포네이트 유도체의 제조방법 | |
CN117683016A (zh) | 手性3,4-二取代胺基吡啶催化剂的合成及在Black重排中的应用 | |
WO2009102043A1 (ja) | 光学活性な4-アミノ-3-(3,4-ジクロロフェニル)ブタン-1-オールの製造方法およびその中間体 |